Stage IV Squamous Cell Carcinoma of the Nasopharynx Completed Phase 1 Trials for Hydroxyurea (DB01005)

IndicationStatusPhase
DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00023959Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerTreatment